The promise of paclitaxel-peptide conjugates for MMP-2-targeted drug delivery.
Huang
Ying
Y
Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, NY, USA. huangy@upstate.edu
Shi
Jingxue
J
He
Qin
Q
Sheikh
M Saeed
MS
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000494:pharmacology; D016503:Drug Delivery Systems; D006801:Humans; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism*; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009842:Oligopeptides / Q000494:pharmacology*; D017239:Paclitaxel / Q000008:administration & dosage* / Q000494:pharmacology; D011355:Prodrugs / Q000494:pharmacology*
D000972:Antineoplastic Agents, Phytogenic; D009842:Oligopeptides; D011355:Prodrugs; D020778:Matrix Metalloproteinase 2; D017239:Paclitaxel